Clinical Trials Using Anti-CD166 Probody-drug Conjugate CX-2009
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-CD166 Probody-drug Conjugate CX-2009. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer
A Phase 2, clinical study in advanced, metastatic breast cancer that will evaluate CX-2009 monotherapy in both Hormone Receptor(HR) positive / HER2 negative breast cancer and in TNBC, and evaluate CX-2009+CX-072 in TNBC
Location: 4 locations